Redcare Pharmacy NV (XETRA:RDC) — Market Cap & Net Worth
Market Cap & Net Worth: Redcare Pharmacy NV (RDC)
Redcare Pharmacy NV (XETRA:RDC) has a market capitalization of $901.38 Million (€771.00 Million) as of June 19, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #9526 globally and #1172 in its home market, demonstrating a 39.14% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Redcare Pharmacy NV's stock price €67.15 by its total outstanding shares 20341307 (20.34 Million). Review Redcare Pharmacy NV (RDC) total liabilities to assess the company's total debt and financial obligations.
Redcare Pharmacy NV Market Cap History: 2016 to 2026
Redcare Pharmacy NV's market capitalization history from 2016 to 2026. Data shows growth from $642.09 Million to $1.60 Billion (7.93% CAGR).
Index Memberships
Redcare Pharmacy NV is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
HDAX Performance
GDAXHI
|
$1.21 Trillion | 0.07% | #56 of 99 |
|
HDAX Price
GDAXHIP
|
$1.23 Trillion | 0.07% | #58 of 102 |
|
DAX Midcap
MDAXI
|
$190.95 Billion | 0.47% | #31 of 49 |
|
DAX Midcap Price
MKDX
|
$184.09 Billion | 0.49% | #31 of 50 |
Weight: Redcare Pharmacy NV's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Redcare Pharmacy NV Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Redcare Pharmacy NV's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.53x
Redcare Pharmacy NV's market cap is 0.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $642.09 Million | $177.39 Million | -$18.45 Million | 3.62x | N/A |
| 2017 | $1.10 Billion | $283.99 Million | -$21.36 Million | 3.88x | N/A |
| 2018 | $894.17 Million | $539.71 Million | -$33.61 Million | 1.66x | N/A |
| 2019 | $1.03 Billion | $701.01 Million | -$36.27 Million | 1.48x | N/A |
| 2020 | $3.52 Billion | $968.06 Million | -$16.77 Million | 3.64x | N/A |
| 2021 | $2.69 Billion | $1.06 Billion | -$74.19 Million | 2.54x | N/A |
| 2022 | $1.05 Billion | $1.20 Billion | -$77.65 Million | 0.87x | N/A |
| 2023 | $3.13 Billion | $1.80 Billion | -$12.04 Million | 1.74x | N/A |
| 2024 | $3.13 Billion | $2.37 Billion | -$45.46 Million | 1.32x | N/A |
| 2025 | $1.55 Billion | $2.94 Billion | -$37.70 Million | 0.53x | N/A |
Competitor Companies of RDC by Market Capitalization
Companies near Redcare Pharmacy NV in the global market cap rankings as of June 19, 2026.
Key companies related to Redcare Pharmacy NV by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1706 globally with a market cap of $14.35 Billion USD ( €12.27 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2203 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2574 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3306 globally with a market cap of $5.68 Billion USD ( R$28.94 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1706 | JD HEALTH INTL LTD | F:8ZN | $14.35 Billion | €3.82 |
| #2203 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2574 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3306 | Raia Drogasil S.A | SA:RADL3 | $5.68 Billion | R$16.55 |
Redcare Pharmacy NV Historical Marketcap From 2016 to 2026
Between 2016 and today, Redcare Pharmacy NV's market cap moved from $642.09 Million to $ 1.60 Billion, with a yearly change of 7.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.60 Billion | +3.15% |
| 2025 | €1.55 Billion | -50.57% |
| 2024 | €3.13 Billion | +0.08% |
| 2023 | €3.13 Billion | +198.35% |
| 2022 | €1.05 Billion | -61.07% |
| 2021 | €2.69 Billion | -23.55% |
| 2020 | €3.52 Billion | +240.69% |
| 2019 | €1.03 Billion | +15.69% |
| 2018 | €894.17 Million | -18.88% |
| 2017 | €1.10 Billion | +71.67% |
| 2016 | €642.09 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Redcare Pharmacy NV was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $901.38 Million USD |
| MoneyControl | $901.38 Million USD |
| MarketWatch | $901.38 Million USD |
| marketcap.company | $901.38 Million USD |
| Reuters | $901.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Redcare Pharmacy NV
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare P… Read more